Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd? von Davis, Ian D.

Volltext

TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol AN... von Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret, Davis, Ian D.

Volltext

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial von Sternberg, Cora N, Davis, Ian D, Mardiak, Jozef, Szczylik, Cezary, Lee, Eunsik, Wagstaff, John, Barrios, Carlos H, Salman, Pamela, Gladkov, Oleg A, Kavina, Alexander, Zarbá, Juan J, Chen, Mei, McCann, Lauren, Pandite, Lini, Roychowdhury, Debasish F, Hawkins, Robert E

Volltext

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial von Motzer, Robert J, Dr Prof, Porta, Camillo, MD, Vogelzang, Nicholas J, Prof, Sternberg, Cora N, MD, Szczylik, Cezary, Prof, Zolnierek, Jakub, MD, Kollmannsberger, Christian, MD, Rha, Sun Young, MD, Bjarnason, Georg A, MD, Melichar, Bohuslav, Prof, De Giorgi, Ugo, MD, Grünwald, Viktor, Prof, Davis, Ian D, MBBS, Lee, Jae-Lyun, Prof, Esteban, Emilio, Prof, Urbanowitz, Gladys, MBA, Cai, Can, PhD, Squires, Matthew, PhD, Marker, Mahtab, PhD, Shi, Michael M, MD, Escudier, Bernard, Prof

Volltext

Breast and prostate cancer: more similar than different von Risbridger, Gail P, Davis, Ian D, Birrell, Stephen N, Tilley, Wayne D

Volltext

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial von Chambers, Suzanne K, Occhipinti, Stefano, Foley, Elizabeth, Clutton, Samantha, Legg, Melissa, Berry, Martin, Stockler, Martin R, Frydenberg, Mark, Gardiner, Robert A, Lepore, Stephen J, Davis, Ian D, Smith, David P

Volltext

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma von HUTSON, Thomas E, DAVIS, Ian D, PANDITE, Lini, FIGLIN, Robert A, MACHIELS, Jean-Pascal H, DE SOUZA, Paul L, ROTTEY, Sylvie, HONG, Bao-Fa, EPSTEIN, Richard J, BAKER, Katherine L, MCCANN, Lauren, CROFTS, Theresa

Volltext

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer von Whitford, Hayley S., Kalinowski, Pawel, Schembri, Adrian, Grimison, Peter, Stockler, Martin, Martin, Andrew, Toner, Guy C., Davis, Ian D., Maruff, Paul, Olver, Ian N.

Volltext

Be Careful Not To ARAMIS the Point von Davis, Ian D.

Volltext

Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas von QI ZHAO, CABALLERO, Otavia L, DAVIS, Ian D, JONASCH, Eric, TAMBOLI, Pheroze, YUNG, W. K. Alfred, WEINSTEIN, John N, SHAW, Kenna, STRAUSBERG, Robert L, JUN YAO

Volltext

A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma von Ebert, Lisa M, MacRaild, Sarah E, Zanker, Damien, Davis, Ian D, Cebon, Jonathan, Chen, Weisan

Volltext

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer von Mak, Blossom, Lin, Hui-Ming, Kwan, Edmond M, Fettke, Heidi, Tran, Ben, Davis, Ian D, Mahon, Kate, Stockler, Martin R, Briscoe, Karen, Marx, Gavin, Zhang, Alison, Crumbaker, Megan, Tan, Winston, Huynh, Kevin, Meikle, Thomas G, Mellett, Natalie A, Hoy, Andrew J, Du, Pan, Yu, Jianjun, Jia, Shidong, Joshua, Anthony M, Waugh, David J, Butler, Lisa M, Kohli, Manish, Meikle, Peter J, Azad, Arun A, Horvath, Lisa G

Volltext

Thyrotoxicosis during sunitinib treatment for renal cell carcinoma von Grossmann, Mathis, Premaratne, Erosha, Desai, Jayesh, Davis, Ian D.

Volltext

Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage von Barrow, Catherine, Browning, Judy, MacGregor, Duncan, Davis, Ian D, Sturrock, Sue, Jungbluth, Achim A, Cebon, Jonathan

Volltext

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011 von Evans, Sue M, Millar, Jeremy L, Davis, Ian D, Murphy, Declan G, Bolton, Damien M, Giles, Graham G, Frydenberg, Mark, Andrianopoulos, Nick, Wood, Julie M, Frauman, Albert G, Costello, Anthony J, McNeil, John J

Volltext

Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial von Davis, Ian D, Brady, Ben, Kefford, Richard F, Millward, Michael, Cebon, Jonathan, Skrumsager, Birte K, Mouritzen, Ulrik, Hansen, Lasse Tengbjerg, Skak, Kresten, Lundsgaard, Dorthe, Frederiksen, Klaus Stensgaard, Kristjansen, Paul E G, McArthur, Grant

Volltext

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial von Hofman, Michael S, Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Joshua, Anthony M, Goh, Jeffrey C, Pattison, David A, Tan, Thean Hsiang, Kirkwood, Ian D, Ng, Siobhan, Francis, Roslyn J, Gedye, Craig, Rutherford, Natalie K, Weickhardt, Andrew, Scott, Andrew M, Lee, Sze-Ting, Kwan, Edmond M, Azad, Arun A, Ramdave, Shakher, Redfern, Andrew D, Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Y, McJannett, Margaret M, Stockler, Martin R, Violet, John A, Williams, Scott G, Martin, Andrew J, Davis, Ian D, Azad, Arun A, Chua, Wei, Davis, Ian D, Dhiantravan, Nattakorn, Emmett, Louise, Ford, Kate, Hofman, Michael S, Francis, Roslyn J, Gedye, Craig, Goh, Jeffrey C, Guminski, Alex, Hsiao, Edward, Iravani, Amir, Joshua, Anthony M, Kirkwood, Ian D, Langford, Ailsa, Lawrence, Nicola, Lee, Sze-Ting, Lin, Peter, Martin, Andrew J, McDonald, William, McJannett, Margaret M, Ng, Siobhan, Pattison, David A, Ramdave, Shakher, Rana, Nisha, Redfern, Andrew D, Rutherford, Natalie K, Sandhu, Shahneen, Scott, Andrew M, Stockler, Martin R, Subramaniam, Shalini, Tan, Thean Hsiang, Violet, John A, Weickhardt, Andrew, Williams, Scott G, Yip, Sonia, Zhang, Alison Y

Volltext

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase von Lin, Hui-Ming, Mak, Blossom, Yeung, Nicole, Huynh, Kevin, Meikle, Thomas G., Mellett, Natalie A., Kwan, Edmond M., Fettke, Heidi, Tran, Ben, Davis, Ian D., Mahon, Kate L., Zhang, Alison, Stockler, Martin R., Briscoe, Karen, Marx, Gavin, Crumbaker, Megan, Stricker, Phillip D., Du, Pan, Yu, Jianjun, Jia, Shidong, Scheinberg, Tahlia, Fitzpatrick, Michael, Bonnitcha, Paul, Sullivan, David R., Joshua, Anthony M., Azad, Arun A., Butler, Lisa M., Meikle, Peter J., Horvath, Lisa G.

Volltext

Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma von NICHOLAOU, Theo, EBERT, Lisa M, LINDA PAN, VENHAUS, Ralph, HOFFMAN, Eric W, CHEN, Weisan, CEBON, Jonathan, DAVIS, Ian D, MCARTHUR, Grant A, JACKSON, Heather, DIMOPOULOS, Nektaria, TAN, Bee, MARASKOVSKY, Eugene, MILORADOVIC, Lena, HOPKINS, Wendie

Volltext

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial von Galsky, Matthew D, Arija, José Ángel Arranz, Bamias, Aristotelis, Davis, Ian D, De Santis, Maria, Kikuchi, Eiji, Garcia-del-Muro, Xavier, De Giorgi, Ugo, Mencinger, Marina, Izumi, Kouji, Panni, Stefano, Gumus, Mahmut, Özgüroğlu, Mustafa, Kalebasty, Arash Rezazadeh, Park, Se Hoon, Alekseev, Boris, Schutz, Fabio A, Li, Jian-Ri, Ye, Dingwei, Vogelzang, Nicholas J, Bernhard, Sandrine, Tayama, Darren, Mariathasan, Sanjeev, Mecke, Almut, Thåström, AnnChristine, Grande, Enrique

Volltext